Ferrer Internacional Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRER INTERNACIONAL, and when can generic versions of FERRER INTERNACIONAL drugs launch?
FERRER INTERNACIONAL has one approved drug.
There are two US patents protecting FERRER INTERNACIONAL drugs.
There are thirty-three patent family members on FERRER INTERNACIONAL drugs in twenty-three countries and seven supplementary protection certificates in seven countries.
Summary for Ferrer Internacional
International Patents: | 33 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Ferrer Internacional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,180,200 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,399,014 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ferrer Internacional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | 6,335,447 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ferrer Internacional Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Chile | 2011000848 | ⤷ Sign Up |
Russian Federation | 2011119764 | ⤷ Sign Up |
South Korea | 20110071086 | ⤷ Sign Up |
South Korea | 101682256 | ⤷ Sign Up |
Japan | 5873120 | ⤷ Sign Up |
European Patent Office | 2177208 | ⤷ Sign Up |
European Patent Office | 2344130 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ferrer Internacional Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2344130 | 1790031-7 | Sweden | ⤷ Sign Up | PRODUCT NAME: OZENOXACIN; NAT. REG. NO/DATE: 54608 20170622; FIRST REG.: BE ES/H/414/01/DC 20170519 |
2344130 | 2017/038 | Ireland | ⤷ Sign Up | PRODUCT NAME: OZENOXACIN; NAT REGISTRATION NO/DATE: PA1744/003/001 20170616; FIRST REGISTRATION NO/DATE: ES/H/414/01/DC 20170519 |
2344130 | 122017000073 | Germany | ⤷ Sign Up | PRODUCT NAME: OZENOXACIN; NAT. REGISTRATION NO/DATE: 97303.00.00 20170803; FIRST REGISTRATION: BELGIEN BE509591 20170517 |
2344130 | 2017C/031 | Belgium | ⤷ Sign Up | PRODUCT NAME: OZENOXACINE; AUTHORISATION NUMBER AND DATE: BE509591 20170519 |
2344130 | 300884 | Netherlands | ⤷ Sign Up | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
2344130 | 132017000093887 | Italy | ⤷ Sign Up | PRODUCT NAME: OZENOXACIN(DUBINE); AUTHORISATION NUMBER(S) AND DATE(S): ES/H/414/01/DC, 20170519;045237017, 20170711 |
2344130 | C201730036 | Spain | ⤷ Sign Up | PRODUCT NAME: OZENOXACINO; NATIONAL AUTHORISATION NUMBER: 82357-ES/H/0414/001/DC; DATE OF AUTHORISATION: 20170830; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): ES/H/414/01/DC; DATE OF FIRST AUTHORISATION IN EEA: 20170519 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.